J. Bahn, J. Lee, G. Li, C. Greer, G. Peng et al., Accurate identification of A-to-I RNA editing in human by transcriptome sequencing, Genome Research, vol.22, issue.1, pp.142-50
DOI : 10.1101/gr.124107.111

P. Barraud and F. Allain, ADAR Proteins: Double-stranded RNA and Z-DNA Binding Domains, Curr Top Microbiol Immunol, vol.353, pp.35-60, 2012.
DOI : 10.1007/82_2011_145

URL : https://hal.archives-ouvertes.fr/hal-00606932

C. Basilio, A. Wahba, P. Lengyel, J. Speyer, and S. Ochoa, SYNTHETIC POLYNUCLEOTIDES AND THE AMINO ACID CODE, V, Proceedings of the National Academy of Sciences, vol.48, issue.4, pp.613-619, 1962.
DOI : 10.1073/pnas.48.4.613

B. Bass, RNA Editing by Adenosine Deaminases That Act on RNA, Annual Review of Biochemistry, vol.71, issue.1, pp.817-863, 2002.
DOI : 10.1146/annurev.biochem.71.110601.135501

L. Bazak, A. Haviv, M. Barak, J. Jacob-hirsch, P. Deng et al., A-to-I RNA editing occurs at over a hundred million genomic sites, located in a majority of human genes, Genome Research, vol.24, issue.3, pp.365-76, 2014.
DOI : 10.1101/gr.164749.113

L. Bazak, E. Levanon, and E. Eisenberg, Genome-wide analysis of Alu editability, Nucleic Acids Research, vol.42, issue.11, pp.6876-84, 2014.
DOI : 10.1093/nar/gku414

A. Beghini, C. Ripamonti, P. Peterlongo, G. Roversi, R. Cairoli et al., RNA hyperediting and alternative splicing of hematopoietic cell phosphatase (PTPN6) gene in acute myeloid leukemia, Human Molecular Genetics, vol.9, issue.15, pp.2297-304, 2000.
DOI : 10.1093/oxfordjournals.hmg.a018921

R. Benne, J. Van-den-burg, J. Brakenhoff, P. Sloof, V. Boom et al., Major transcript of the frameshifted coxll gene from trypanosome mitochondria contains four nucleotides that are not encoded in the DNA, Cell, vol.46, issue.6, pp.819-845, 1986.
DOI : 10.1016/0092-8674(86)90063-2

M. Blow, R. Grocock, S. Van-dongen, A. Enright, E. Dicks et al., RNA editing of human microRNAs, Genome Biology, vol.7, issue.4, p.27, 2006.
DOI : 10.1186/gb-2006-7-4-r27

M. Bousquet, C. Quelen, R. Rosati, V. Mansat-de-mas, L. Starza et al., Myeloid cell differentiation arrest by miR-125b-1 in myelodysplasic syndrome and acute myeloid leukemia with the t(2;11)(p21;q23) translocation, The Journal of Experimental Medicine, vol.55, issue.11, pp.2499-506, 2008.
DOI : 10.1084/jem.178.6.1995

G. Calin and C. Croce, MicroRNA signatures in human cancers, Nature Reviews Cancer, vol.59, issue.11, pp.857-66, 2006.
DOI : 10.1677/erc.1.01209

S. Castaigne, C. Chomienne, M. Daniel, P. Ballerini, R. Berger et al., Alltrans retinoic acid as a differentiation therapy for acute promyelocytic leukemia I Clinical results, Blood, vol.76, issue.9, pp.1704-1713, 1990.

C. Cenci, R. Barzotti, F. Galeano, S. Corbelli, R. Rota et al., Down-regulation of RNA Editing in Pediatric Astrocytomas: ADAR2 EDITING ACTIVITY INHIBITS CELL MIGRATION AND PROLIFERATION, Journal of Biological Chemistry, vol.283, issue.11, pp.7251-60, 2008.
DOI : 10.1074/jbc.M708316200

C. Chen, D. Cho, Q. Wang, F. Lai, K. Carter et al., A third member of the RNA-specific adenosine deaminase gene family, ADAR3, contains both single- and double-stranded RNA binding domains, RNA, vol.6, issue.5, pp.755-67, 2000.
DOI : 10.1017/S1355838200000170

K. Cheng, P. Sportoletti, K. Ito, J. Clohessy, J. Teruya-feldstein et al., The cytoplasmic NPM mutant induces myeloproliferation in a transgenic mouse model, Blood, vol.115, issue.16, pp.3341-3346, 2010.
DOI : 10.1182/blood-2009-03-208587

D. Cho, Y. W. Lee, J. Shiekhattar, R. Murray, J. Nishikura et al., Requirement of Dimerization for RNA Editing Activity of Adenosine Deaminases Acting on RNA, Journal of Biological Chemistry, vol.278, issue.19, pp.17093-102, 2003.
DOI : 10.1074/jbc.M213127200

Y. Choudhury, F. Tay, D. Lam, E. Sandanaraj, C. Tang et al., Attenuated adenosine-to-inosine editing of microRNA-376a* promotes invasiveness of glioblastoma cells, Journal of Clinical Investigation, vol.122, issue.11, pp.4059-76, 2012.
DOI : 10.1172/JCI62925DS1

D. Weer, A. Speleman, F. Cauwelier, B. Van-roy, N. Yigit et al., Groupe Français de Cytogénétique Hématologique (GFCH), EVI1 overexpression in t, vol.17, issue.3, 2008.

M. Deininger, E. Buchdunger, and B. Druker, The development of imatinib as a therapeutic agent for chronic myeloid leukemia, Blood, vol.105, issue.7, pp.2640-53, 2005.
DOI : 10.1182/blood-2004-08-3097

S. Der, A. Zhou, B. Williams, and R. Silverman, Identification of genes differentially regulated by interferon ??, ??, or ?? using oligonucleotide arrays, Proceedings of the National Academy of Sciences, vol.95, issue.26, pp.15623-15631, 1998.
DOI : 10.1073/pnas.95.26.15623

B. Deschler and M. Lübbert, Acute myeloid leukemia: epidemiology and etiology. Cancer, pp.2099-107, 2006.

J. Desterro, L. Keegan, M. Lafarga, M. Berciano, O. Connell et al., Dynamic association of RNA-editing enzymes with the nucleolus, Journal of Cell Science, vol.116, issue.9, pp.1805-1823, 2003.
DOI : 10.1242/jcs.00371

J. Desterro, L. Keegan, E. Jaffray, R. Hay, O. Connell et al., SUMO-1 Modification Alters ADAR1 Editing Activity, Molecular Biology of the Cell, vol.16, issue.11, pp.5115-5141, 2005.
DOI : 10.1091/mbc.E05-06-0536

D. Croce, L. Raker, V. Corsaro, M. Fazi, F. Fanelli et al., Methyltransferase Recruitment and DNA Hypermethylation of Target Promoters by an Oncogenic Transcription Factor, Science, vol.295, issue.5557, pp.1079-82, 2002.
DOI : 10.1126/science.1065173

A. Dobin, C. Davis, F. Schlesinger, J. Drenkow, C. Zaleski et al., STAR: ultrafast universal RNA-seq aligner, Bioinformatics, vol.29, issue.1, pp.15-21, 2013.
DOI : 10.1093/bioinformatics/bts635

H. Döhner, E. Estey, S. Amadori, F. Appelbaum, T. Büchner et al., Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet, Blood, vol.115, issue.3, pp.453-74, 2010.
DOI : 10.1182/blood-2009-07-235358

M. Doria, F. Neri, A. Gallo, M. Farace, and A. Michienzi, Editing of HIV-1 RNA by the doublestranded RNA deaminase ADAR1 stimulates viral infection, Nucleic Acids Res, 2009.

J. Eggington, T. Greene, and B. Bass, Predicting sites of ADAR editing in double-stranded RNA, Nature Communications, vol.269, p.319, 2011.
DOI : 10.1093/nar/gkg595

E. Eisenberg, K. Adamsky, L. Cohen, N. Amariglio, A. Hirshberg et al., Identification of RNA editing sites in the SNP database, Nucleic Acids Research, vol.33, issue.14, pp.4612-4619, 2005.
DOI : 10.1093/nar/gki771

L. Federici and B. Falini, Nucleophosmin mutations in acute myeloid leukemia: A tale of protein unfolding and mislocalization, Protein Science, vol.2, issue.5, pp.545-56, 2013.
DOI : 10.1002/pro.2240

Y. Feng, C. Sansam, M. Singh, and R. Emeson, Altered RNA Editing in Mice Lacking ADAR2 Autoregulation, Molecular and Cellular Biology, vol.26, issue.2, pp.480-488, 2006.
DOI : 10.1128/MCB.26.2.480-488.2006

M. Figueroa, S. Lugthart, Y. Li, C. Erpelinck-verschueren, X. Deng et al., DNA methylation signatures identify biologically distinct subtypes in acute myeloid leukemia. Cancer Cell, pp.13-27, 2010.

J. Fritz, A. Strehblow, A. Taschner, S. Schopoff, P. Pasierbek et al., RNA-Regulated Interaction of Transportin-1 and Exportin-5 with the Double-Stranded RNA-Binding Domain Regulates Nucleocytoplasmic Shuttling of ADAR1, Molecular and Cellular Biology, vol.29, issue.6, pp.1487-97, 2009.
DOI : 10.1128/MCB.01519-08

F. Galeano, C. Rossetti, S. Tomaselli, L. Cifaldi, M. Lezzerini et al., ADAR2-editing activity inhibits glioblastoma growth through the modulation of the CDC14B/Skp2/p21/p27 axis, Oncogene, vol.10, issue.8, pp.998-1009, 2013.
DOI : 10.1038/onc.2012.125

A. Gallo and S. Galardi, A-to-I RNA editing and cancer: From pathology to basic science, RNA Biology, vol.5, issue.3, pp.135-144, 2008.
DOI : 10.4161/rna.5.3.6739

S. Gandy, S. Linnstaedt, S. Muralidhar, K. Cashman, L. Rosenthal et al., RNA Editing of the Human Herpesvirus 8 Kaposin Transcript Eliminates Its Transforming Activity and Is Induced during Lytic Replication, Journal of Virology, vol.81, issue.24, pp.13544-51, 2007.
DOI : 10.1128/JVI.01521-07

C. George and C. Samuel, Human RNA-specific adenosine deaminase ADAR1 transcripts possess alternative exon 1 structures that initiate from different promoters, one constitutively active and the other interferon inducible, Proceedings of the National Academy of Sciences, vol.96, issue.8, pp.4621-4627, 1999.
DOI : 10.1073/pnas.96.8.4621

C. George, M. Wagner, and C. Samuel, Expression of Interferon-inducible RNA Adenosine Deaminase ADAR1 during Pathogen Infection and Mouse Embryo Development Involves Tissue-selective Promoter Utilization and Alternative Splicing, Journal of Biological Chemistry, vol.280, issue.15, pp.15020-15028, 2005.
DOI : 10.1074/jbc.M500476200

A. Gerber, O. Connell, M. Keller, and W. , Two forms of human double-stranded RNA-specific editase 1 (hRED1) generated by the insertion of an Alu cassette, RNA, 1997.

A. Gerber and W. Keller, RNA editing by base deamination: more enzymes, more targets, new mysteries, Trends in Biochemical Sciences, vol.26, issue.6, pp.376-84, 2001.
DOI : 10.1016/S0968-0004(01)01827-8

S. Grisendi and P. Pandolfi, Mutations in Acute Myelogenous Leukemia, New England Journal of Medicine, vol.352, issue.3, pp.291-293, 2005.
DOI : 10.1056/NEJMe048337

D. Grover, M. Mukerji, P. Bhatnagar, K. Kannan, and S. Brahmachari, Alu repeat analysis in the complete human genome: trends and variations with respect to genomic composition, Bioinformatics, vol.20, issue.6, pp.813-820, 2004.
DOI : 10.1093/bioinformatics/bth005

T. Gu, F. Buaas, A. Simons, C. Ackert-bicknell, R. Braun et al., Canonical A-to-I and C-to-U RNA Editing Is Enriched at 3???UTRs and microRNA Target Sites in Multiple Mouse Tissues, PLoS ONE, vol.39, issue.3, p.33720, 2012.
DOI : 10.1371/journal.pone.0033720.s010

J. Hartner, C. Schmittwolf, A. Kispert, A. Müller, M. Higuchi et al., Liver Disintegration in the Mouse Embryo Caused by Deficiency in the RNA-editing Enzyme ADAR1, Journal of Biological Chemistry, vol.279, issue.6, pp.4894-902, 2004.
DOI : 10.1074/jbc.M311347200

J. Hartner, C. Walkley, J. Lu, and S. Orkin, ADAR1 is essential for the maintenance of hematopoiesis and suppression of interferon signaling, Nature Immunology, vol.275, issue.1, pp.109-124, 2009.
DOI : 10.1038/ni.1680

F. Hayakawa, M. Towatari, H. Kiyoi, M. Tanimoto, T. Kitamura et al., Tandemduplicated Flt3 constitutively activates STAT5 and MAP kinase and introduces autonomous cell growth in IL-3-dependent cell lines, Oncogene. Feb, vol.319, issue.5, pp.624-655, 2000.

A. Herbert, M. Schade, K. Lowenhaupt, J. Alfken, T. Schwartz et al., The Zalpha domain from human ADAR1 binds to the Z-DNA conformer of many different sequences, Nucleic Acids Research, vol.26, issue.15, pp.3486-93, 1998.
DOI : 10.1093/nar/26.15.3486

M. Higuchi, F. Single, M. Köhler, B. Sommer, R. Sprengel et al., RNA editing of AMPA receptor subunit GluR-B: A base-paired intron-exon structure determines position and efficiency, Cell, vol.75, issue.7, pp.1361-70, 1993.
DOI : 10.1016/0092-8674(93)90622-W

M. Higuchi, S. Maas, F. Single, J. Hartner, A. Rozov et al., Point mutation in an AMPA receptor gene rescues lethality in mice deficient in the RNA-editing enzyme ADAR2, Nature, vol.406, issue.6791, pp.78-81, 2000.

M. Hochberg, L. Gilead, G. Markel, Y. Nemlich, Y. Feiler et al., Insulin-like growth factor-binding protein-7 (IGFBP7) transcript: A-to-I editing events in normal and cancerous human keratinocytes, Archives of Dermatological Research, vol.141, issue.Suppl, 2013.
DOI : 10.1007/s00403-013-1338-5

R. Hough and B. Bass, Purification of the Xenopus laevis double-stranded RNA adenosine deaminase, J Biol Chem, vol.269, issue.13, pp.9933-9942, 1994.

H. Iizasa, B. Wulff, N. Alla, M. Maragkakis, M. Megraw et al., Editing of Epstein-Barr Virus-encoded BART6 MicroRNAs Controls Their Dicer Targeting and Consequently Affects Viral Latency, Journal of Biological Chemistry, vol.285, issue.43, pp.33358-70, 2010.
DOI : 10.1074/jbc.M110.138362

H. Iizasa and K. Nishikura, A new function for the RNA-editing enzyme ADAR1, Nature Immunology, vol.10, issue.1, pp.16-24, 2009.
DOI : 10.1038/nsmb1041

S. Ishiuchi, Y. Yoshida, K. Sugawara, M. Aihara, T. Ohtani et al., Ca2+-Permeable AMPA Receptors Regulate Growth of Human Glioblastoma via Akt Activation, Journal of Neuroscience, vol.27, issue.30, pp.7987-8001, 2007.
DOI : 10.1523/JNEUROSCI.2180-07.2007

M. Jacobs, R. Fogg, R. Emeson, and G. Stanwood, ADAR1 and ADAR2 Expression and Editing Activity during Forebrain Development, Developmental Neuroscience, vol.31, issue.3, pp.223-260, 2009.
DOI : 10.1159/000210185

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2692045

Q. Jiang, L. Crews, C. Barrett, H. Chun, A. Court et al., ADAR1 promotes malignant progenitor reprogramming in chronic myeloid leukemia, Proceedings of the National Academy of Sciences, vol.110, issue.3, pp.1041-1047, 2013.
DOI : 10.1073/pnas.1213021110

Y. Jin, W. Zhang, and Q. Li, Origins and evolution of ADAR-mediated RNA editing. IUBMB Life, pp.572-580, 2009.

Y. Kawahara, K. Ito, M. Ito, S. Tsuji, and S. Kwak, Novel splice variants of human ADAR2 mRNA: Skipping of the exon encoding the dsRNA-binding domains, and multiple C-terminal splice sites, Gene, vol.363, pp.193-201, 2005.
DOI : 10.1016/j.gene.2005.07.028

Y. Kawahara, M. Megraw, E. Kreider, H. Iizasa, L. Valente et al., Frequency and fate of microRNA editing in human brain, Nucleic Acids Research, vol.36, issue.16, 2008.
DOI : 10.1093/nar/gkn479

Y. Kawahara, B. Zinshteyn, T. Chendrimada, R. Shiekhattar, and K. Nishikura, RNA editing of the microRNA-151 precursor blocks cleavage by the Dicer-TRBP complex. EMBO Rep, pp.763-772, 2007.

Y. Kawahara, B. Zinshteyn, P. Sethupathy, H. Iizasa, A. Hatzigeorgiou et al., Redirection of silencing targets by adenosine-to-inosine editing of miRNAs. Science, Feb, vol.23315, issue.5815, pp.1137-1177, 2007.

L. Keegan, A. Leroy, D. Sproul, O. Connell, and M. , Adenosine deaminases acting on RNA (ADARs): RNA-editing enzymes, Genome Biology, vol.5, issue.2, p.209, 2004.
DOI : 10.1186/gb-2004-5-2-209

D. Kim, T. Kim, T. Walsh, Y. Kobayashi, T. Matise et al., Widespread RNA Editing of Embedded Alu Elements in the Human Transcriptome, Genome Research, vol.14, issue.9, 2004.
DOI : 10.1101/gr.2855504

U. Kim, Y. Wang, T. Sanford, Y. Zeng, and K. Nishikura, Molecular cloning of cDNA for double-stranded RNA adenosine deaminase, a candidate enzyme for nuclear RNA editing., Proceedings of the National Academy of Sciences, vol.91, issue.24, pp.11457-61, 1994.
DOI : 10.1073/pnas.91.24.11457

A. Kiran and P. Baranov, DARNED: a DAtabase of RNa EDiting in humans, Bioinformatics, vol.26, issue.14, pp.1772-1778, 2010.
DOI : 10.1093/bioinformatics/btq285

P. Kottaridis, R. Gale, S. Langabeer, M. Frew, D. Bowen et al., Studies of FLT3 mutations in paired presentation and relapse samples from patients with acute myeloid leukemia: implications for the role of FLT3 mutations in leukemogenesis, minimal residual disease detection, and possible therapy with FLT3 inhibitors, Blood, vol.100, issue.7, pp.2393-2401, 2002.
DOI : 10.1182/blood-2002-02-0420

A. Kuttan and B. Bass, Mechanistic insights into editing-site specificity of ADARs, Proceedings of the National Academy of Sciences, vol.109, issue.48, pp.3295-304, 2012.
DOI : 10.1073/pnas.1212548109

J. Lamoril, N. Ameziane, J. Deybach, P. Bouizegarène, and M. Bogard, Le monde complexe et mouvant des ARN. Immuno-analyse et biologie spécialisée, pp.4-25, 2010.
DOI : 10.1016/j.immbio.2010.01.002

M. Lanfranco, P. Seitz, M. Morabito, R. Emeson, E. Sanders-bush et al., An innovative real-time PCR method to measure changes in RNA editing of the serotonin 2C receptor (5-HT2CR) in brain, Journal of Neuroscience Methods, vol.179, issue.2, pp.247-57, 2009.
DOI : 10.1016/j.jneumeth.2009.01.027

D. Laxminarayana, I. Khan, O. Rourke, K. Giri, and B. , Induction of 150-kDa adenosine deaminase that acts on RNA (ADAR)-1 gene expression in normal T lymphocytes by anti-CD3-?? and anti-CD28, Immunology, vol.92, issue.4, pp.623-656, 2007.
DOI : 10.1093/nar/gkm314

J. Lee, J. Ang, and X. X. , Analysis and design of RNA sequencing experiments for identifying RNA editing and other single-nucleotide variants, RNA, vol.19, issue.6, pp.725-757, 2013.
DOI : 10.1261/rna.037903.112

K. Lehmann and B. Bass, The importance of internal loops within RNA substrates of ADAR1, Journal of Molecular Biology, vol.291, issue.1, pp.1-13, 1999.
DOI : 10.1006/jmbi.1999.2914

E. Levanon, E. Eisenberg, R. Yelin, S. Nemzer, M. Hallegger et al., Systematic identification of abundant A-to-I editing sites in the human transcriptome, Nature Biotechnology, vol.75, issue.8, pp.1001-1006, 2004.
DOI : 10.1517/phgs.4.6.779.22821

H. Liang and L. Landweber, Hypothesis: RNA editing of microRNA target sites in humans?, RNA, vol.13, issue.4, pp.463-470, 2007.
DOI : 10.1261/rna.296407

Y. Liu, C. George, J. Patterson, and C. Samuel, Functionally distinct double-stranded RNAbinding domains associated with alternative splice site variants of the interferon-inducible double-stranded RNA-specific adenosine deaminase, J Biol Chem. Feb, vol.14272, issue.7, pp.4419-4447, 1997.

H. Lomeli, J. Mosbacher, T. Melcher, T. Höger, J. Geiger et al., Control of kinetic properties of AMPA receptor channels by nuclear RNA editing, Science, vol.266, issue.5191, pp.1709-1722, 1994.
DOI : 10.1126/science.7992055

A. Look, Oncogenic transcription factors in the human acute leukemias. Science, Nov, vol.7278, issue.5340, pp.1059-64, 1997.

C. Ma, J. Chong, Y. Guo, H. Zeng, S. Liu et al., Abnormal expression of ADAR1 isoforms in Chinese pediatric acute leukemias, Biochemical and Biophysical Research Communications, vol.406, issue.2, pp.245-51, 2011.
DOI : 10.1016/j.bbrc.2011.02.025

S. Maas, A. Gerber, and A. Rich, Identification and characterization of a human tRNA-specific adenosine deaminase related to the ADAR family of pre-mRNA editing enzymes, Proceedings of the National Academy of Sciences, vol.96, issue.16, pp.8895-900, 1999.
DOI : 10.1073/pnas.96.16.8895

S. Maas and W. Gommans, Novel Exon of Mammalian ADAR2 Extends Open Reading Frame, PLoS ONE, vol.282, issue.1, p.4225, 2009.
DOI : 10.1371/journal.pone.0004225.g004

S. Maas and W. Gommans, Identification of a selective nuclear import signal in adenosine deaminases acting on RNA, Nucleic Acids Research, vol.37, issue.17, pp.5822-5831, 2009.
DOI : 10.1093/nar/gkp599

S. Maas, Y. Kawahara, K. Tamburro, and K. Nishikura, A-to-I RNA Editing and Human Disease, RNA Biology, vol.3, issue.1, pp.1-9, 2006.
DOI : 10.4161/rna.3.1.2495

S. Maas, S. Patt, M. Schrey, and A. Rich, Underediting of glutamate receptor GluR-B mRNA in malignant gliomas, Proceedings of the National Academy of Sciences, vol.98, issue.25, pp.14687-92, 2001.
DOI : 10.1073/pnas.251531398

M. Macbeth, H. Schubert, A. Vandemark, A. Lingam, C. Hill et al., Inositol Hexakisphosphate Is Bound in the ADAR2 Core and Required for RNA Editing, Science, vol.309, issue.5740, pp.1534-1543, 2005.
DOI : 10.1126/science.1113150

R. Marcucci, J. Brindle, S. Paro, A. Casadio, S. Hempel et al., Q/R site RNA editing by ADAR2 with opposing effects, The EMBO Journal, vol.419, issue.20, pp.4211-4233, 2011.
DOI : 10.1038/emboj.2011.303

E. Mardis, L. Ding, D. Dooling, D. Larson, M. Mclellan et al., Recurring Mutations Found by Sequencing an Acute Myeloid Leukemia Genome, New England Journal of Medicine, vol.361, issue.11, pp.1058-66, 2009.
DOI : 10.1056/NEJMoa0903840

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3201812

T. Melcher, S. Maas, M. Higuchi, W. Keller, and P. Seeburg, Editing of ??-Amino-3-hydroxy-5-methylisoxazole-4-propionic Acid Receptor GluR-B Pre-mRNA in Vitro Reveals Site-selective Adenosine to Inosine Conversion, Journal of Biological Chemistry, vol.270, issue.15, pp.8566-70, 1995.
DOI : 10.1074/jbc.270.15.8566

T. Melcher, S. Maas, A. Herb, R. Sprengel, P. Seeburg et al., A mammalian RNA editing enzyme, Nature, vol.379, issue.6564, pp.460-464, 1996.
DOI : 10.1038/379460a0

L. Mittaz, H. Scott, C. Rossier, P. Seeburg, M. Higuchi et al., Cloning of a Human RNA Editing Deaminase (ADARB1) of Glutamate Receptors That Maps to Chromosome 21q22.3, Genomics, vol.41, issue.2, pp.210-217, 1997.
DOI : 10.1006/geno.1997.4655

D. Nachmani, A. Zimmermann, O. Djian, E. Weisblum, Y. Livneh et al., MicroRNA Editing Facilitates Immune Elimination of HCMV Infected Cells, PLoS Pathogens, vol.25, issue.2, p.1003963, 2014.
DOI : 10.1371/journal.ppat.1003963.s009

Y. Nemlich, E. Greenberg, R. Ortenberg, M. Besser, I. Barshack et al., MicroRNA-mediated loss of ADAR1 in metastatic melanoma promotes tumor growth, Journal of Clinical Investigation, vol.123, issue.6, pp.2703-2721, 2013.
DOI : 10.1172/JCI62980DS1

Y. Nie, G. Hammond, and J. Yang, Double-Stranded RNA Deaminase ADAR1 Increases Host Susceptibility to Virus Infection, Journal of Virology, vol.81, issue.2, pp.917-940, 2007.
DOI : 10.1128/JVI.01527-06

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1797455

Y. Nie, L. Ding, P. Kao, R. Braun, and J. Yang, ADAR1 Interacts with NF90 through Double-Stranded RNA and Regulates NF90-Mediated Gene Expression Independently of RNA Editing, Molecular and Cellular Biology, vol.25, issue.16, pp.6956-63, 2005.
DOI : 10.1128/MCB.25.16.6956-6963.2005

K. Nishikura, Functions and Regulation of RNA Editing by ADAR Deaminases, Annual Review of Biochemistry, vol.79, issue.1, pp.321-370, 2010.
DOI : 10.1146/annurev-biochem-060208-105251

D. Oh, Y. Kim, and A. Rich, Z-DNA-binding proteins can act as potent effectors of gene expression in vivo, Proceedings of the National Academy of Sciences, vol.99, issue.26, pp.16666-71, 2002.
DOI : 10.1073/pnas.262672699

S. Osenberg, P. Yaacov, N. Safran, M. Moshkovitz, S. Shtrichman et al., Alu sequences in undifferentiated human embryonic stem cells display high levels of A-to-I RNA editing PLoS One, 2010.

T. Pabst and B. Mueller, Complexity of CEBPA dysregulation in human acute myeloid leukemia. Clin Cancer Res, pp.5303-5310, 2009.

T. Pabst, B. Mueller, P. Zhang, H. Radomska, S. Narravula et al., Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-alpha (C/EBPalpha), in acute myeloid leukemia, Nature Genetics, vol.27, issue.3, pp.263-70, 2001.
DOI : 10.1038/85820

S. Park, Activation-induced Cytidine Deaminase in B Cell Immunity and Cancers. Immune Netw, pp.230-239, 2012.

J. Patterson, D. Thomis, S. Hans, and C. Samuel, Mechanism of Interferon Action: Double-Stranded RNA-Specific Adenosine Deaminase from Human Cells Is Inducible by Alpha and Gamma Interferons, Virology, vol.210, issue.2, pp.508-519, 1995.
DOI : 10.1006/viro.1995.1370

N. Paz, E. Levanon, N. Amariglio, A. Heimberger, Z. Ram et al., Altered adenosine-to-inosine RNA editing in human cancer, Genome Research, vol.17, issue.11, pp.1586-95, 2007.
DOI : 10.1101/gr.6493107

P. Peng, X. Zhong, W. Tu, M. Soundarapandian, P. Molner et al., ADAR2-Dependent RNA Editing of AMPA Receptor Subunit GluR2 Determines Vulnerability of Neurons in Forebrain Ischemia, Neuron, vol.49, issue.5, pp.719-752, 2006.
DOI : 10.1016/j.neuron.2006.01.025

Z. Peng, Y. Cheng, B. Tan, L. Kang, Z. Tian et al., Comprehensive analysis of RNA-Seq data reveals extensive RNA editing in a human transcriptome, Nature Biotechnology, vol.460, issue.3, pp.253-60, 2012.
DOI : 10.1038/nature06884

A. Polson, B. Bass, and J. Casey, RNA editing of hepatitis delta virus antigenome by dsRNA-adenosine deaminase, Nature, vol.380, issue.6573, pp.454-460, 1996.

A. Polson and B. Bass, Preferential selection of adenosines for modification by doublestranded RNA adenosine deaminase, EMBO J, vol.13, issue.23, pp.5701-5712, 1994.

H. Poulsen, J. Nilsson, C. Damgaard, J. Egebjerg, and J. Kjems, CRM1 Mediates the Export of ADAR1 through a Nuclear Export Signal within the Z-DNA Binding Domain, Molecular and Cellular Biology, vol.21, issue.22, pp.7862-71, 2001.
DOI : 10.1128/MCB.21.22.7862-7871.2001

L. Powell, S. Wallis, R. Pease, Y. Edwards, T. Knott et al., A novel form of tissue-specific RNA processing produces apolipoprotein-B48 in intestine, Cell, vol.50, issue.6, pp.831-871, 1987.
DOI : 10.1016/0092-8674(87)90510-1

W. Qiu, X. Wang, M. Buchanan, K. He, R. Sharma et al., ADAR1 is essential for intestinal homeostasis and stem cell maintenance, Cell Death and Disease, vol.4, issue.4, p.599, 2013.
DOI : 10.1016/S1097-2765(01)00213-1

C. Quelen, La translocation chromosomique t(X;6)(p11;q23) dans la leucémie aiguë à basophiles, 2011.

G. Ramaswami and J. Li, RADAR: a rigorously annotated database of A-to-I RNA editing, Nucleic Acids Research, vol.42, issue.D1, pp.109-122
DOI : 10.1093/nar/gkt996

G. Ramaswami, R. Zhang, R. Piskol, L. Keegan, P. Deng et al., Identifying RNA editing sites using RNA sequencing data alone, Nature Methods, vol.38, issue.2, pp.128-160, 2013.
DOI : 10.1038/nmeth.2330

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3676881

G. Ramaswami, W. Lin, R. Piskol, M. Tan, C. Davis et al., Accurate identification of human Alu and non-Alu RNA editing sites, Nature Methods, vol.467, issue.6, pp.579-81
DOI : 10.1038/nmeth.1982

D. Rawlings, M. Schwartz, S. Jackson, and A. Meyer-bahlburg, Integration of B cell responses through Toll-like receptors and antigen receptors, Nature Reviews Immunology, vol.28, issue.4, pp.282-94, 2012.
DOI : 10.1038/nri3190

L. Rieder, C. Staber, B. Hoopengardner, and R. Reenan, Tertiary structural elements determine the extent and specificity of messenger RNA editing, Nature Communications, vol.12, p.2232, 2013.
DOI : 10.1105/tpc.109.066001

S. Rueter, T. Dawson, and R. Emeson, Regulation of alternative splicing by RNA editing, Nature, vol.399, issue.6731, pp.75-80, 1999.

S. Rueter, C. Burns, S. Coode, P. Mookherjee, and R. Emeson, Glutamate receptor RNA editing in vitro by enzymatic conversion of adenosine to inosine. Science, pp.1491-1495, 1995.

M. Sakurai, T. Yano, H. Kawabata, H. Ueda, and T. Suzuki, Inosine cyanoethylation identifies A-to-I RNA editing sites in the human transcriptome, Nature Chemical Biology, vol.14, issue.10, pp.733-773, 2010.
DOI : 10.1038/nchembio.434

C. Sansam, K. Wells, and R. Emeson, Modulation of RNA editing by functional nucleolar sequestration of ADAR2, Proceedings of the National Academy of Sciences, vol.100, issue.24, pp.14018-14041, 2003.
DOI : 10.1073/pnas.2336131100

L. Saunders and G. Barber, The dsRNA binding protein family: critical roles, diverse cellular functions, The FASEB Journal, vol.17, issue.9, pp.961-83, 2003.
DOI : 10.1096/fj.02-0958rev

Y. Savva, L. Rieder, and R. Reenan, The ADAR protein family, Genome Biology, vol.13, issue.12, p.252, 2012.
DOI : 10.1126/science.1169957

A. Scadden, The RISC subunit Tudor-SN binds to hyper-edited double-stranded RNA and promotes its cleavage, Nature Structural & Molecular Biology, vol.17, issue.6, pp.489-96, 2005.
DOI : 10.1093/nar/gkh303

A. Scadden and C. Smith, RNAi is antagonized by A???I hyper-editing, EMBO reports, vol.106, issue.12, pp.1107-1118, 2001.
DOI : 10.1093/embo-reports/kve244

V. Schoft, S. Schopoff, and M. Jantsch, Regulation of glutamate receptor B pre-mRNA splicing by RNA editing, Nucleic Acids Research, vol.35, issue.11, pp.3723-3755, 2007.
DOI : 10.1093/nar/gkm314

P. Seeburg, M. Higuchi, and R. Sprengel, RNA editing of brain glutamate receptor channels: mechanism and physiology, Brain Res Brain Res Rev, vol.26, pp.2-3217, 1998.

R. Sharma, Y. Wang, P. Zhou, R. Steinman, and Q. Wang, An essential role of RNA editing enzyme ADAR1 in mouse skin, Journal of Dermatological Science, vol.64, issue.1, pp.70-72, 2011.
DOI : 10.1016/j.jdermsci.2011.06.013

E. Shtivelman, B. Lifshitz, R. Gale, and E. Canaani, Fused transcript of abl and bcr genes in chronic myelogenous leukaemia, Nature, vol.74, issue.6020, pp.550-554, 1985.
DOI : 10.1038/315550a0

R. Shtrichman, I. Germanguz, R. Mandel, A. Ziskind, I. Nahor et al., Altered A-to-I RNA Editing in Human Embryogenesis, PLoS ONE, vol.7, issue.7, p.41576, 2012.
DOI : 10.1371/journal.pone.0041576.s003

B. Sommer, M. Köhler, R. Sprengel, and P. Seeburg, RNA editing in brain controls a determinant of ion flow in glutamate-gated channels. Cell, pp.11-20, 1991.

R. Steinman, Q. Yang, M. Gasparetto, L. Robinson, X. Liu et al., Deletion of the RNA-editing enzyme ADAR1 causes regression of established chronic myelogenous leukemia in mice, International Journal of Cancer, vol.119, issue.Suppl 1, pp.1741-50, 2013.
DOI : 10.1002/ijc.27851

O. Stephens, B. Haudenschild, and P. Beal, The Binding Selectivity of ADAR2's dsRBMs Contributes to RNA-Editing Selectivity, Chemistry & Biology, vol.11, issue.9, pp.1239-50, 2004.
DOI : 10.1016/j.chembiol.2004.06.009

A. Strehblow, M. Hallegger, and M. Jantsch, Nucleocytoplasmic distribution of human RNAediting enzyme ADAR1 is modulated by double-stranded RNA-binding domains, a leucine-rich export signal, and a putative dimerization domain, Mol Biol Cell, 2002.

D. Taylor, M. Puig, M. Darnell, K. Mihalik, and S. Feinstone, New Antiviral Pathway That Mediates Hepatitis C Virus Replicon Interferon Sensitivity through ADAR1, Journal of Virology, vol.79, issue.10, pp.6291-6299, 2005.
DOI : 10.1128/JVI.79.10.6291-6298.2005

E. Thomas, J. Cancelas, Y. Zheng, and D. Williams, Rac GTPases as key regulators of p210-BCR-ABL-dependent leukemogenesis. Leukemia, pp.898-904, 2008.

S. Tomaselli, B. Bonamassa, A. Alisi, V. Nobili, F. Locatelli et al., ADAR Enzyme and miRNA Story: A Nucleotide that Can Make the Difference, International Journal of Molecular Sciences, vol.14, issue.11, pp.22796-816, 2013.
DOI : 10.3390/ijms141122796

A. Toth, Z. Li, R. Cattaneo, and C. Samuel, RNA-specific Adenosine Deaminase ADAR1 Suppresses Measles Virus-induced Apoptosis and Activation of Protein Kinase PKR, Journal of Biological Chemistry, vol.284, issue.43, pp.29350-29356, 2009.
DOI : 10.1074/jbc.M109.045146

I. Uribesalgo, D. Croce, and L. , Dynamics of epigenetic modifications in leukemia, Briefings in Functional Genomics, vol.10, issue.1, pp.18-29, 2011.
DOI : 10.1093/bfgp/elr002

J. Vardiman, J. Thiele, D. Arber, R. Brunning, M. Borowitz et al., The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes, Blood, vol.114, issue.5, pp.937-51, 2009.
DOI : 10.1182/blood-2009-03-209262

H. Wahlstedt, C. Daniel, M. Ensterö, and M. Ohman, Large-scale mRNA sequencing determines global regulation of RNA editing during brain development, Genome Research, vol.19, issue.6, 2009.
DOI : 10.1101/gr.089409.108

I. Wang, E. So, J. Devlin, Y. Zhao, M. Wu et al., ADAR regulates RNA editing, transcript stability, and gene expression. Cell Rep, pp.849-60, 2013.
DOI : 10.1016/j.celrep.2013.10.002

URL : http://doi.org/10.1016/j.celrep.2013.10.002

Q. Wang, RNA editing catalyzed by ADAR1 and its function in mammalian cells, Biochemistry (Moscow), vol.76, issue.8, pp.900-911, 2011.
DOI : 10.1134/S0006297911080050

Q. Wang, O. Brien, P. Chen, C. Cho, D. Murray et al., Altered G Protein-Coupling Functions of RNA Editing Isoform and Splicing Variant Serotonin2C Receptors, Journal of Neurochemistry, vol.74, issue.3, pp.1290-300, 2000.
DOI : 10.1046/j.1471-4159.2000.741290.x

Q. Wang, J. Khillan, P. Gadue, and K. Nishikura, Requirement of the RNA Editing Deaminase ADAR1 Gene for Embryonic Erythropoiesis, Science, vol.290, issue.5497, pp.1765-1773, 2000.
DOI : 10.1126/science.290.5497.1765

Q. Wang, M. Miyakoda, W. Yang, J. Khillan, D. Stachura et al., Stressinduced apoptosis associated with null mutation of ADAR1 RNA editing deaminase gene, J Biol Chem. Feb, vol.6279, issue.6, pp.4952-61, 2004.

Y. Wang and C. Samuel, Adenosine Deaminase ADAR1 Increases Gene Expression at the Translational Level by Decreasing Protein Kinase PKR-Dependent eIF-2?? Phosphorylation, Journal of Molecular Biology, vol.393, issue.4, pp.777-87, 2009.
DOI : 10.1016/j.jmb.2009.08.070

Z. Wang, M. Choi, T. Ban, H. Yanai, H. Negishi et al., Regulation of innate immune responses by DAI (DLM-1/ZBP1) and other DNA-sensing molecules, Proceedings of the National Academy of Sciences, vol.105, issue.14, pp.5477-82, 2008.
DOI : 10.1073/pnas.0801295105

H. Weier, C. George, K. Greulich, and C. Samuel, The Interferon-Inducible, Double-Stranded RNA-Specific Adenosine Deaminase Gene (DSRAD) Maps to Human Chromosome 1q21.1???21.2, Genomics, vol.30, issue.2, pp.372-377, 1995.
DOI : 10.1006/geno.1995.0034

B. Wulff and K. Nishikura, Substitutional A-to-I RNA editing, Wiley Interdisciplinary Reviews - RNA, vol.49, issue.1, pp.90-101, 2010.
DOI : 10.1002/wrna.10

B. Wulff, M. Sakurai, and K. Nishikura, Elucidating the inosinome: global approaches to adenosine-to-inosine RNA editing, Nature Reviews Genetics, vol.31, issue.2, pp.81-86, 2011.
DOI : 10.1038/nrg2915

R. Xufeng, M. Boyer, H. Shen, Y. Li, H. Yu et al., ADAR1 is required for hematopoietic progenitor cell survival via RNA editing, Proceedings of the National Academy of Sciences, vol.106, issue.42, pp.17763-17771, 2009.
DOI : 10.1073/pnas.0903324106

Y. Yamamoto, H. Kiyoi, Y. Nakano, R. Suzuki, Y. Kodera et al., Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies. Blood, pp.2434-2443, 2001.

J. Yang, X. Luo, Y. Nie, Y. Su, Q. Zhao et al., Widespread inosine-containing mRNA in lymphocytes regulated by ADAR1 in response to inflammation, Immunology, vol.10, issue.1, pp.15-23, 2003.
DOI : 10.1038/19992

W. Yang, T. Chendrimada, Q. Wang, M. Higuchi, P. Seeburg et al., Modulation of microRNA processing and expression through RNA editing by ADAR deaminases, Nature Structural & Molecular Biology, vol.376, issue.1, pp.13-21, 2006.
DOI : 10.1038/nsmb1041

H. Yi-brunozzi, O. Stephens, and P. Beal, Conformational changes that occur during an RNA-editing adenosine deamination reaction, J Biol Chem, vol.276, issue.41, pp.37827-37860, 2001.

H. Yoshida, K. Kitamura, K. Tanaka, S. Omura, T. Miyazaki et al., Accelerated degradation of PML-retinoic acid receptor alpha (PML-RARA) oncoprotein by all-trans-retinoic acid in acute promyelocytic leukemia: possible role of the proteasome pathway, Cancer Res, vol.56, issue.13, pp.2945-2953, 1996.

L. Zhang, J. Huang, N. Yang, J. Greshock, M. Megraw et al., microRNAs exhibit high frequency genomic alterations in human cancer, Proceedings of the National Academy of Sciences, vol.103, issue.24, pp.9136-9177, 2006.
DOI : 10.1073/pnas.0508889103